Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 |
| Revenues | 24.4 | 21.0 | 9.1 |
| Revenue growth | 16.3% | 131.0% | |
| Cost of goods sold | 36.3 | 26.3 | 11.1 |
| Gross profit | -11.8 | -5.3 | -2.0 |
| Gross margin | -48.5% | -25.3% | -22.0% |
| Selling, general and administrative | 51.6 | 42.9 | 10.5 |
| Research and development | 9.6 | 3.1 | 1.3 |
| EBIT | -73.1 | -51.2 | -13.8 |
| EBIT margin | -299.4% | -244.1% | -151.4% |
| Pre-tax income | 15.2 | -100.8 | -37.7 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% |
| Net income | 15.2 | -100.8 | -37.7 |
| Net margin | 62.1% | -480.0% | -414.3% |
| |
| Diluted EPS | $0.18 | ($1.67) | ($1.25) |
| Shares outstanding (diluted) | 85.6 | 60.3 | 30.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|